Systemic Drugs Associated With Maculopathy

Macular DiseasesRetinal Diseases

Systemic and ocular associated factors for pathologic myopia in a highly myopic Chinese population: findings from the Wenzhou pathologic myopia study

Br J Ophthalmol

Zhao J, Gong Q, Jiang Y, Han J, Zhu X, Li M, Lu F, Hu L

doi: 10.1136/bjo-2025-327438

Uveitis

Immune Checkpoint Inhibitor-Associated Uveitis: Insights from Comparative Analyses Across Malignancies and Drug Classes

Am J Ophthalmol

Bellanda V, Schulgit MJ, Hassan KA, Kennedy LB, Barbosa GCS, Mizuno Y, Mohan N, Kaelber DC, Srivastava SK, Sharma S

doi: 10.1016/j.ajo.2026.05.046

Uveitis

Isolated tattoo-associated uveitis without systemic sarcoidosis: A systematic review of case reports

Surv Ophthalmol

Ghalibafan S, Herskowitz WR, Chou BG, Rohowetz LJ, Gutkind NE, Llop SM, Yannuzzi NA

doi: 10.1016/j.survophthal.2025.09.021

Further Publications

Pentosan Polysulfate Maculopathy Following Subcutaneous Injections for Arthritis

JAMA Ophthalmol

Fung AT, Sarraf D, Carrillo JM, Feo A, Faghihi S, Borie CM, Lim L, Hunyor AP, Yannuzzi NA

doi: 10.1001/jamaophthalmol.2025.5069

Glaucoma and Ocular PressureRetinal Diseases

Association Between Pseudoexfoliation Glaucoma and Central Serous Chorioretinopathy

Am J Ophthalmol

Abboud I, Fam A, Almobayed A, Guillaume GI, ElSheikh RH, Lee RK, Elhusseiny AM

doi: 10.1016/j.ajo.2026.03.009

Surgery and InterventionCataracts

Correlation Between Endothelial Morphology, Ocular Biometric Parameters, and Systemic Comorbidities in a Large Caucasian Cohort

J Clin Med

Martinez-de-la-Casa M, Matilla M, Garcia-Bella J, Morales Fernandez L, Garcia-Feijoo J, Martínez-de-la-Casa JM, Burgos-Blasco B

doi: 10.3390/jcm15155815

Retinal Diseases

Progression of hydroxychloroquine-induced retinopathy after drug cessation

Graefes Arch Clin Exp Ophthalmol

Brown RB, Kitay AM, Driban M, Zur D, Kniestedt C, Barthelmes D, Sadeghi E, Chhablani JK, Al-Sheikh M

doi: 10.1007/s00417-025-07037-8

Further Publications

Systemic and Metabolic Profile of Sagging Eye Syndrome: A Comparative Analysis

Am J Ophthalmol

Yehezkeli V, Kim JJ, Velez FG, Demer JL, Pineles SL

doi: 10.1016/j.ajo.2025.11.040

Further Publications

Peri-Event Intravitreal Anti-VEGF and Systemic Outcomes After Stroke or Myocardial Infarction

JAMA Ophthalmol

Bordbar DD, Mukhtar AO, Loya A, Alsoudi AF, Muayad J, Chauhan MZ, Patel NA, Sallam AB, Weng CY

doi: 10.1001/jamaophthalmol.2026.0460

Related content

Systemic and ocular associated factors for pathologic myopia in a highly myopic Chinese population: findings from the Wenzhou pathologic myopia study

Immune Checkpoint Inhibitor-Associated Uveitis: Insights from Comparative Analyses Across Malignancies and Drug Classes

Isolated tattoo-associated uveitis without systemic sarcoidosis: A systematic review of case reports

Pentosan Polysulfate Maculopathy Following Subcutaneous Injections for Arthritis

Association Between Pseudoexfoliation Glaucoma and Central Serous Chorioretinopathy

Correlation Between Endothelial Morphology, Ocular Biometric Parameters, and Systemic Comorbidities in a Large Caucasian Cohort

Progression of hydroxychloroquine-induced retinopathy after drug cessation

Systemic and Metabolic Profile of Sagging Eye Syndrome: A Comparative Analysis

Peri-Event Intravitreal Anti-VEGF and Systemic Outcomes After Stroke or Myocardial Infarction